Brief: Casi Pharmaceuticals Inc - On May 23, Terminated Original License Agreement Dated Sept 17, 2014 Between Spectrum Pharmaceuticals Cayman, Lp, Co
25/05/2022 22:29
May 25 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS INC - ON MAY 23, TERMINATED ORIGINAL
LICENSE AGREEMENT DATED SEPT 17, 2014 BETWEEN SPECTRUM
PHARMACEUTICALS CAYMAN, LP, CO
* CASI PHARMACEUTICALS INC - ACROTECH BIOPHARMA LLC ASSUMED
ORIGINAL LICENSE AGREEMENT FROM SPECTRUM
Further company coverage: CASI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary